Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · June 04, 2020

Tumor Mutational Burden and Immune Infiltration as Independent Predictors of Response to Neoadjuvant Immune Checkpoint Inhibition in Early TNBC

Annals of Oncology

 

Additional Info

Annals of Oncology
Tumor Mutational Burden and Immune Infiltration as Independent Predictors of Response to Neoadjuvant Immune Checkpoint Inhibition in Early TNBC in GeparNuevo
Ann. Oncol 2020 May 24;[EPub Ahead of Print], T Karn, C Denkert, KE Weber, U Holtrich, C Hanusch, BV Sinn, BW Higgs, P Jank, HP Sinn, J Huober, C Becker, JU Blohmer, F Marmé, WD Schmitt, S Wu, M van Mackelenbergh, V Müller, C Schem, E Stickeler, PA Fasching, C Jackisch, M Untch, A Schneeweiss, S Loibl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading